ClinConnect ClinConnect Logo
Search / Trial NCT02722096

Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications

Launched by HOSPICES CIVILS DE LYON · Mar 23, 2016

Trial Information

Current as of May 15, 2025

Completed

Keywords

Arteriovenous Fistula Regional Anesthesia Local Anesthesia Early Complication

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chronic kidney disease stade 4 or 5
  • First creation of arteriovenous fistula on the side of the surgery
  • written consent
  • Health care system adherent
  • No decision of juridical protection
  • Exclusion Criteria:
  • Pregnancy or breast-feeding
  • Participation to an other research study that may interfere with this study
  • Brachial arterio-venous fistula creation (upper elbow crease)
  • Antecedent of homolateral arteriovenous fistula (controlateral fistula non excluded)
  • Other surgery on arteriovenous fistula (superficialisation procedure, refection...)
  • Contraindications to local anesthetics : Ropivacaine or Lidocaine allergy
  • Contraindication to regional anesthesia : homolateral axillary lymphadenectomy

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, , France

Patients applied

0 patients applied

Trial Officials

Thomas RIMMELE, MD, PhD

Principal Investigator

Hopital Edouard Herriot, Hospices Civils de Lyon, France

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials